drugset / Trial / NCT03096392
Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Multi-Center, double blind, active comparator controlled multiple dose safety, tolerability and efficacy study
Timeline
- Start
- 2017-04-18
- Primary completion
- 2017-11-15
- Completion
- 2018-03-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HDV Insulin Lispro | Protein / enzyme biologic | — | Subcutaneous |
| Comparator | Insulin Lispro | Protein / enzyme biologic | — | Subcutaneous |